Each year, the specialist biopharma publication names 15 of the ‘best and brightest in biotech’, recognising the boundary-pushing biotechs at an award ceremony at the Fierce Biotech Summit in Boston, ...
Kimer Med co-founder Philip Oliver has put part of his 27% stake in the Nelson-based biotech company up for sale on the Catalist exchange. He and CEO Rick Kiessig co-founded the company in 2020 during ...
12 month contract focused on the development of new antiviral drugs Novel candidates to be produced using Kimer Med's broad-spectrum antiviral platform There are currently no approved antivirals for ...
Nelson, New Zealand – 25 Jan 2024 – Ground-breaking New Zealand biotech start-up, Kimer Med, has launched a capital raise to complete pre-clinical studies on its broad-spectrum antivirals, ahead of ...
The 12 month contract is funded by the United States government through the Defense Threat Reduction Agency (DTRA), and will fall into Battelle's Accelerated Therapeutics for Combating Acute Viral ...
Kimer Med, a Nelson biotech start-up, announced it has signed a contract valued at up to USD$ 750,000 (NZD$ 1.3 million) with Battelle Memorial Institute (Battelle), the world’s largest independent, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results